HEADER HYDROLASE/HYDROLASE INHIBITOR 26-JAN-10 3LJG TITLE HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE METALLOELASTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MMP-12 CATALITIC SUBUNIT (RESIDUES 106-263); COMPND 5 SYNONYM: MME, MATRIX METALLOPROTEINASE-12, MMP-12, MACROPHAGE COMPND 6 ELASTASE, ME, HME; COMPND 7 EC: 3.4.24.65; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MMP12, HME; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET24A KEYWDS MMP12 ELASTASE NON-CHELATING INHIBITOR, HYDROLASE, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,V.DIVE,L.DEVEL,L.VERA,F.BEAU REVDAT 4 06-SEP-23 3LJG 1 REMARK SEQADV LINK REVDAT 3 17-JUL-19 3LJG 1 REMARK ATOM REVDAT 2 08-DEC-10 3LJG 1 JRNL REVDAT 1 01-SEP-10 3LJG 0 JRNL AUTH L.DEVEL,S.GARCIA,B.CZARNY,F.BEAU,E.LAJEUNESSE,L.VERA, JRNL AUTH 2 D.GEORGIADIS,E.STURA,V.DIVE JRNL TITL INSIGHTS FROM SELECTIVE NON-PHOSPHINIC INHIBITORS OF MMP-12 JRNL TITL 2 TAILORED TO FIT WITH AN S1' LOOP CANONICAL CONFORMATION. JRNL REF J.BIOL.CHEM. V. 285 35900 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20817735 JRNL DOI 10.1074/JBC.M110.139634 REMARK 2 REMARK 2 RESOLUTION. 1.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.440 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 39775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.6005 - 3.1632 1.00 2849 181 0.1510 0.1635 REMARK 3 2 3.1632 - 2.5112 1.00 2754 142 0.1556 0.1737 REMARK 3 3 2.5112 - 2.1939 1.00 2757 132 0.1577 0.1802 REMARK 3 4 2.1939 - 1.9934 1.00 2700 144 0.1470 0.1778 REMARK 3 5 1.9934 - 1.8505 1.00 2676 164 0.1550 0.1957 REMARK 3 6 1.8505 - 1.7414 1.00 2683 140 0.1649 0.1934 REMARK 3 7 1.7414 - 1.6542 1.00 2692 139 0.1681 0.2352 REMARK 3 8 1.6542 - 1.5822 1.00 2676 146 0.1812 0.2106 REMARK 3 9 1.5822 - 1.5213 1.00 2689 117 0.1877 0.2283 REMARK 3 10 1.5213 - 1.4688 1.00 2670 144 0.1936 0.2178 REMARK 3 11 1.4688 - 1.4229 1.00 2672 130 0.2254 0.2216 REMARK 3 12 1.4229 - 1.3822 1.00 2647 131 0.2369 0.2442 REMARK 3 13 1.3822 - 1.3458 1.00 2669 140 0.2620 0.2972 REMARK 3 14 1.3458 - 1.3130 1.00 2643 148 0.2979 0.2806 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 48.01 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.15650 REMARK 3 B22 (A**2) : -0.05190 REMARK 3 B33 (A**2) : 0.20840 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1406 REMARK 3 ANGLE : 1.090 1903 REMARK 3 CHIRALITY : 0.072 192 REMARK 3 PLANARITY : 0.019 247 REMARK 3 DIHEDRAL : 18.144 518 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3LJG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000057352. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.855 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39828 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.310 REMARK 200 RESOLUTION RANGE LOW (A) : 32.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : 0.10700 REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.30 REMARK 200 R MERGE FOR SHELL (I) : 0.76600 REMARK 200 R SYM FOR SHELL (I) : 0.81100 REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: RIGID BODY REMARK 200 SOFTWARE USED: REFMAC (RIGID BODY) REMARK 200 STARTING MODEL: PDB ENTRY 3LIR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MMP12 AT 4MG/ML CO-CRYSTALLIZATION REMARK 280 WITH AHA AND NON-CHELATING INHIBITOR WITH PRECIPITANT: 19% PEG REMARK 280 10K, 0.2M IMIDAZOLE MALATE, PH 8.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 34.54500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.54500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 O16 P6G A 304 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 52 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 C15 P6G A 304 O16 P6G A 304 2565 1.40 REMARK 500 O HOH A 472 O HOH A 481 4555 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 206 -154.65 -138.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 P6G A 304 REMARK 610 P6G A 305 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 266 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 5 O REMARK 620 2 HOH A 54 O 92.3 REMARK 620 3 ASP A 158 O 83.8 87.7 REMARK 620 4 GLY A 190 O 87.8 84.7 168.4 REMARK 620 5 GLY A 192 O 79.7 171.8 93.3 93.0 REMARK 620 6 ASP A 194 OD2 166.9 99.0 90.1 99.7 89.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 267 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 12 O REMARK 620 2 HOH A 21 O 79.8 REMARK 620 3 ASP A 124 OD2 95.7 135.5 REMARK 620 4 ASP A 124 OD1 84.3 85.3 50.2 REMARK 620 5 GLU A 199 O 108.1 81.9 139.6 160.2 REMARK 620 6 GLU A 199 OE2 164.2 88.7 84.8 84.0 80.7 REMARK 620 7 GLU A 201 O 78.8 142.0 77.9 123.1 75.4 116.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 265 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 168 NE2 REMARK 620 2 ASP A 170 OD1 109.4 REMARK 620 3 HIS A 183 NE2 122.1 108.8 REMARK 620 4 HIS A 196 ND1 106.9 96.7 109.9 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 268 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 175 OD2 REMARK 620 2 GLY A 176 O 86.2 REMARK 620 3 GLY A 178 O 84.4 87.4 REMARK 620 4 ILE A 180 O 93.6 177.9 90.5 REMARK 620 5 ASP A 198 OD1 96.3 88.9 176.2 93.2 REMARK 620 6 GLU A 201 OE2 169.4 92.0 85.1 87.8 94.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 264 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 218 NE2 REMARK 620 2 HIS A 222 NE2 99.1 REMARK 620 3 HIS A 228 NE2 101.2 97.1 REMARK 620 4 HAE A 301 O 93.5 97.8 157.1 REMARK 620 5 HAE A 301 O2 123.2 137.1 82.6 74.7 REMARK 620 6 HAE A 301 O 177.3 78.2 79.7 86.6 59.4 REMARK 620 7 HAE A 301 O2 106.2 94.4 148.2 12.8 68.9 73.8 REMARK 620 8 HAE A 301 N 148.9 106.6 92.8 66.3 31.2 33.2 55.4 REMARK 620 N 1 2 3 4 5 6 7 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(3-BIPHENYL-4-YLPROPANOYL)-L-ALPHA-GLUTAMYL-L- REMARK 630 ALPHA-GLUTAMYL-AMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 EEF A 302 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 0YF GLU GLU NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 264 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 265 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 266 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 267 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 268 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HAE A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EEF A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P6G A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P6G A 305 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LIK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIL RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIR RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR DBREF 3LJG A 106 263 UNP P39900 MMP12_HUMAN 106 263 SEQADV 3LJG MET A 105 UNP P39900 EXPRESSION TAG SEQADV 3LJG ASP A 171 UNP P39900 PHE 171 ENGINEERED MUTATION SEQRES 1 A 159 MET GLY PRO VAL TRP ARG LYS HIS TYR ILE THR TYR ARG SEQRES 2 A 159 ILE ASN ASN TYR THR PRO ASP MET ASN ARG GLU ASP VAL SEQRES 3 A 159 ASP TYR ALA ILE ARG LYS ALA PHE GLN VAL TRP SER ASN SEQRES 4 A 159 VAL THR PRO LEU LYS PHE SER LYS ILE ASN THR GLY MET SEQRES 5 A 159 ALA ASP ILE LEU VAL VAL PHE ALA ARG GLY ALA HIS GLY SEQRES 6 A 159 ASP ASP HIS ALA PHE ASP GLY LYS GLY GLY ILE LEU ALA SEQRES 7 A 159 HIS ALA PHE GLY PRO GLY SER GLY ILE GLY GLY ASP ALA SEQRES 8 A 159 HIS PHE ASP GLU ASP GLU PHE TRP THR THR HIS SER GLY SEQRES 9 A 159 GLY THR ASN LEU PHE LEU THR ALA VAL HIS GLU ILE GLY SEQRES 10 A 159 HIS SER LEU GLY LEU GLY HIS SER SER ASP PRO LYS ALA SEQRES 11 A 159 VAL MET PHE PRO THR TYR LYS TYR VAL ASP ILE ASN THR SEQRES 12 A 159 PHE ARG LEU SER ALA ASP ASP ILE ARG GLY ILE GLN SER SEQRES 13 A 159 LEU TYR GLY HET ZN A 264 1 HET ZN A 265 1 HET CA A 266 1 HET CA A 267 1 HET CA A 268 1 HET HAE A 301 10 HET EEF A 302 35 HET P6G A 304 7 HET P6G A 305 14 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM HAE ACETOHYDROXAMIC ACID HETNAM EEF N-(3-BIPHENYL-4-YLPROPANOYL)-L-ALPHA-GLUTAMYL-L-ALPHA- HETNAM 2 EEF GLUTAMYL-AMIDE HETNAM P6G HEXAETHYLENE GLYCOL HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CA 3(CA 2+) FORMUL 7 HAE C2 H5 N O2 FORMUL 8 EEF C25 H29 N3 O7 FORMUL 9 P6G 2(C12 H26 O7) FORMUL 11 HOH *327(H2 O) HELIX 1 1 ASN A 126 ASN A 143 1 18 HELIX 2 2 LEU A 212 GLY A 225 1 14 HELIX 3 3 SER A 251 TYR A 262 1 12 SHEET 1 A 5 LYS A 148 LYS A 151 0 SHEET 2 A 5 TYR A 113 ILE A 118 1 N ILE A 114 O LYS A 148 SHEET 3 A 5 ILE A 159 ALA A 164 1 O VAL A 161 N ARG A 117 SHEET 4 A 5 ALA A 195 ASP A 198 1 O PHE A 197 N VAL A 162 SHEET 5 A 5 ALA A 182 ALA A 184 -1 N HIS A 183 O HIS A 196 SHEET 1 B 2 TRP A 203 THR A 204 0 SHEET 2 B 2 THR A 210 ASN A 211 1 O THR A 210 N THR A 204 LINK O HOH A 5 CA CA A 266 1555 1555 2.43 LINK O HOH A 12 CA CA A 267 1555 1555 2.46 LINK O HOH A 21 CA CA A 267 1555 1555 2.45 LINK O HOH A 54 CA CA A 266 1555 1555 2.40 LINK OD2 ASP A 124 CA CA A 267 1555 1555 2.45 LINK OD1 ASP A 124 CA CA A 267 1555 1555 2.68 LINK O ASP A 158 CA CA A 266 1555 1555 2.35 LINK NE2 HIS A 168 ZN ZN A 265 1555 1555 2.00 LINK OD1 ASP A 170 ZN ZN A 265 1555 1555 2.00 LINK OD2 ASP A 175 CA CA A 268 1555 1555 2.37 LINK O GLY A 176 CA CA A 268 1555 1555 2.34 LINK O GLY A 178 CA CA A 268 1555 1555 2.36 LINK O ILE A 180 CA CA A 268 1555 1555 2.32 LINK NE2 HIS A 183 ZN ZN A 265 1555 1555 1.99 LINK O GLY A 190 CA CA A 266 1555 1555 2.36 LINK O GLY A 192 CA CA A 266 1555 1555 2.35 LINK OD2 ASP A 194 CA CA A 266 1555 1555 2.44 LINK ND1 HIS A 196 ZN ZN A 265 1555 1555 2.07 LINK OD1 ASP A 198 CA CA A 268 1555 1555 2.32 LINK O GLU A 199 CA CA A 267 1555 1555 2.39 LINK OE2 GLU A 199 CA CA A 267 1555 1555 2.42 LINK O GLU A 201 CA CA A 267 1555 1555 2.44 LINK OE2 GLU A 201 CA CA A 268 1555 1555 2.34 LINK NE2 HIS A 218 ZN ZN A 264 1555 1555 2.09 LINK NE2 HIS A 222 ZN ZN A 264 1555 1555 2.11 LINK NE2 HIS A 228 ZN ZN A 264 1555 1555 2.11 LINK ZN ZN A 264 O BHAE A 301 1555 1555 2.10 LINK ZN ZN A 264 O2 BHAE A 301 1555 1555 2.19 LINK ZN ZN A 264 O AHAE A 301 1555 1555 2.27 LINK ZN ZN A 264 O2 AHAE A 301 1555 1555 2.39 LINK ZN ZN A 264 N AHAE A 301 1555 1555 2.52 SITE 1 AC1 4 HIS A 218 HIS A 222 HIS A 228 HAE A 301 SITE 1 AC2 4 HIS A 168 ASP A 170 HIS A 183 HIS A 196 SITE 1 AC3 6 HOH A 5 HOH A 54 ASP A 158 GLY A 190 SITE 2 AC3 6 GLY A 192 ASP A 194 SITE 1 AC4 5 HOH A 12 HOH A 21 ASP A 124 GLU A 199 SITE 2 AC4 5 GLU A 201 SITE 1 AC5 6 ASP A 175 GLY A 176 GLY A 178 ILE A 180 SITE 2 AC5 6 ASP A 198 GLU A 201 SITE 1 AC6 13 HOH A 1 HOH A 91 ILE A 180 ALA A 182 SITE 2 AC6 13 HIS A 218 GLU A 219 HIS A 222 HIS A 228 SITE 3 AC6 13 ZN A 264 EEF A 302 HOH A 340 HOH A 393 SITE 4 AC6 13 HOH A 480 SITE 1 AC7 23 HOH A 78 THR A 154 GLY A 155 GLY A 179 SITE 2 AC7 23 LEU A 181 HIS A 218 GLU A 219 PRO A 232 SITE 3 AC7 23 VAL A 235 PHE A 237 PRO A 238 THR A 239 SITE 4 AC7 23 TYR A 240 LYS A 241 HOH A 281 HOH A 288 SITE 5 AC7 23 HAE A 301 HOH A 333 HOH A 377 HOH A 401 SITE 6 AC7 23 HOH A 412 HOH A 415 HOH A 493 SITE 1 AC8 4 HIS A 228 SER A 229 SER A 230 PRO A 238 SITE 1 AC9 11 HOH A 89 TRP A 109 ARG A 110 ASN A 126 SITE 2 AC9 11 ASP A 129 GLY A 188 SER A 189 HOH A 291 SITE 3 AC9 11 HOH A 348 HOH A 394 HOH A 437 CRYST1 69.090 62.820 37.550 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014474 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015918 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026631 0.00000